Referenslitteratur
för:
Cimicifuga racemosa,
Silverax och Remifemin (Ref no 49 - 93, I - P) |
|
| |
FÖRFATTARE
OCH TIDSKRIFT |
PUBLICERAD |
HÄMTA
PDF |
| |
52.
Jacobson JS, Troxel AB, Evans J, et al.:
Randomized trial of black cohosh for the treatment of hot flashes among women
with a history of breast cancer.
J Clin Oncol 19:2739–45; 2001
|
2001 |
Hämta
här |
| |
53.
Jarry H, Gorkow Ch, Wuttke W: Treatment of menopausal symptoms with
Extracts of Cimicifuga Racemosa: In vivo and in
vitro Evidence of
Estrogenic Activity.
In: Loew D, Rietbrock N. Eds. Phytopharmaka in Forschung und klinischer
Anwendung.
Steinkopff Verlag, Darmstadt 1995, pp. 99–112.
|
1995 |
|
| |
54.
Jarry H, Harnischfeger G:
Studies on the endocrine effects of the contents of Cimicifuga racemosa.
2. Influence on the serum concentration of pituitary hormones in
ovariectomized rats.
Planta Medica 1: 46 – 9, 1985.
|
1985 |
|
| |
55.
Jarry H, Harnischfeger G, Dücker EM:
Untersuchungen zur endokrinen Wirksamkeit von Inhaltsstoffen aus
Cimicifuga racemosa. 2. In vitro Bindung von Inhaltsstoffen an Östrogenrezeptoren.
Planta Med 4: 316–9, 1985.
|
1985 |
|
| |
56.
Jarry H, Leonhardt S, Düls C, et al.:
Organ-specific effects of Cimicifuga Racemosa (CR) in Brain and Uterus.
Poster, 23. Int. LOF-Symposium Phyto-Oestrogens, Gent, January
1999.
|
1999 |
|
| |
57.
Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W:
In vitro effects of Cimicifuga racemosa extract BNO 1055.
Maturiras 44, Suppl. 1, pp 1-7; 2003.
|
2003
|
|
| |
58. Jarry H, Thelen P, Christoffel V, Spengler B, Wutthe W
Cimicifuga racemosa extract BNO 1055 inhibits proliferation of the human prostate cancer cell line LNCaP
Phytomedicine 12 (3); 178-82; 2005
|
2005 |
Hämta här |
| |
59.
Johnsson DE, Ochieng J, Evans SL.
The growth inibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells.
Anticancer Drugs 6:471-4; 1995
|
1995 |
Hämta
här |
| |
60.
Kaiser R, Daume E. (Eds.):
Geburtsh und Frauenheilk
25: 974, 1965.
|
1965 |
|
| |
61.
Kesselkaul O:
Über die Behandlung klimakterischer Beschwerden
mit Remifemin.
Medizinische Monatsschrift 11: 87 – 8, 1957.
|
1957 |
|
| |
62.
Kruse SO, Löhning A, Pauli GF, et al.:
Fukiic and piscidic acid esters from the rhizome of Cimicifuga
racemosa and the
in vitro estrogenic activity of fukinolic acid.
Planta Medica 65: 763–4, 1999.
|
1999 |
|
| |
63.
Kuhl H, Taubert H-D. (Eds.):
Das Klimakterium:
Pathophysiologie, Klinik, Therapie.
Stuttgart - New York, Georg Thieme Verlag, pp. 375, 1987.
|
1987 |
|
| |
64.
Kuiper GGJM, Lemmen JG, Carlsson B, et al.:
Interaction of estrogenic chemicals and phytoestrogens with estrogen
receptor beta.
Endocrinology 139: 4252 – 63, 1998.
|
1998 |
|
| |
65.
Kupperman H, Wetchler BB, Meyer HG:
Contemporary Therapy of the Menopausal Syndrome.
J Amer Med Ass 171: 1627 - 37, 1959.
|
1959 |
|
| |
66.
Langfritz W:
Beitrag zur Therapie von Regelanomalien und deren Begleiterscheinungen
bei jungen Mädchen und jungen Frauen.
Med Klinik 57:
1497 - 99, 1962.
|
1962 |
|
| |
67.
Lauritzen C:
Endokrinologie der Prä- und Postmenopause.
Urban & Schwarzenberg Verlag, München 1987.
|
1987 |
|
| |
68.
Lauritzen C:
Altersgynäkologie. Die ältere Frau in der gynäkologischen Sprechstunde:
Prävention, Therapie, Beratung.
Georg Thieme Verlag, Stuttgart, New York, 1997: 195.
|
1997 |
|
| |
69.
Lehmann-Willenbrock E, Riedel H-H:
Klinische und endokrinologische Untersuchungen zur Therapie ovarieller
Ausfallserscheinungen nach Hysterektomie unter Belassung der Adnexe.
Zentralblatt für Gynäkologie 110: 611 – 18, 1988.
|
1988 |
|
| |
70.
Leidenberger F A:
Klinische Endokrinologie für Frauenärzte.
Springer Verlag, Berlin, Heidelberg, 1998, vol 134, pp. 421–3.
|
1998 |
|
| |
71.
Liske E, Boblitz N, Henneicke-von Zepelin H-H:
Therapie klimakterischer Beschwerden mit Cimicifuga
racemosa.
Daten
zur Wirkung und Wirksamkeit aus einer randomisierten kontrollierten
Doppelblindstudie.
Phytopharmaka VI, Norbert Rietbrock (Hrsg.), Steinkopff Verlag,
Darmstadt,
2000, pp. 247 – 57.
|
2000 |
|
| |
72.
Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, et.al.:
Physiological investigation of a unique extract of black cohosh
(Cimicifuga racemosa): A 6-month clinical study demonstrates no systemic estrogenic effect.
J Womens Health Gender Based Med 11, 163-74; 2002.
|
2002
|
|
| |
73.
Liske E, Wüstenberg P:
Therapy of climacteric complaints with Cimicifuga racemosa: herbal
medicine with clinically proven evidence.
Menopause 5(4):250;
1998
|
1998 |
|
| |
74.
Liu J, Burdette JE, Xu H, et al.:
Evaluation of estrogenic activity of plant extracts for the potential treatment
of menopausal symptoms.
J Agric Food Chem 49(5):2472-9; 2001.
|
2001 |
Hämta
här |
| |
75.
Lopes P:
Comments on the Womens Health Initiative (WHI) and the Million Women Study (MWS) which question the usefulness of hormone substitution during menopause.
J Gynecol Obstet Biol Reprod (Paris) 32: 500-2, 2003.
|
2003 |
|
| |
76.
Low Dog, T, Powell K, Weisman M:
Critical evaluation of the safety of Cimicifuga racemosa
in menopause symtom relief.
Menopause 10: 299–313, 2003.
|
2000 |
|
| |
77.
Lundström E, Christow A, Kersemaekers W, et
al.:
Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
Am J Obstet Gynecol 186: 717-22, 2002.
|
2002 |
|
| |
78.
Lupu R, Mwhmi I, Atlas E, et.al.:
Black cohosh, a menopausal remedy, does not have estrogenic activity
and does not promote breast cancer cell growth.
Int J Oncol 23: 1407–12, 2003
|
2003 |
|
| |
79.
Löhning A, Verspohl E J, Winterhoff H:
Cimicifuga
racemosa: In vitro findings using MCF 7 cells.
Abstract P07, Phytopharmakaforschung
2000.
Verlag Science Data Supply, Köln, 1998: 72–3.
|
2000 |
|
| |
80.
Löhning A, Verspohl E J, Winterhoff H:
Pharmacological studies on the dopaminergic activity of Cimicifuga
racemosa.
Poster 23, Int. LOF-Symposium "Phyto-Oestrogens",
Gent, January 1999.
|
1999 |
|
| |
81.
McCoy J, Kelly W:
Survey of Cimicifuga racemosa for phyto-estrogenic flavonoids.
Abstracts of 212:th ACS National Meeting, Orlando, Florida, August
25–29, 1996.
Abstract No. 082.
|
1996 |
|
| |
82.
Madaus G:
Lehrbuch der biologischen Heilmittel.
G. Thieme Verlag, Leipzig, 1938, pp. 983–7.
|
1938 |
|
| |
83.
Martin PM, Horwitz KB, Ryan DS, McGuire WL:
Phytoestrogen interaction with estrogen receptors in human breast
cancer cells.
Endocrinology 103:1860-67, 1978.
|
1978 |
|
| |
84.
Markaverich BM, Shoulars K, Brown MA:
Purification and characterization of nuclear type II [(3)H]estradiolbinding sites
from the rat uterus: covalent labeling with [(3)H]luteolin.
Steroids 66, 707-19; 2001
|
2001
|
|
| |
85.
Messina MJ, Persky P, Setchell KDR, Barnes S:
Soy intake and cancer risk. A review of the in vitro and in vivo data.
Nutrition and Cancer 21:113-31, 1994.
|
1994 |
|
| |
86.
Murray M:
Remifemin: Answers to some common questions.
Am J Nat Med
4(3):3-5; 1997
|
1997 |
|
| |
87.
Naessen T:
The Heart and Estrogen/Progestin Replacement Study (HERS) in perspective — results not very surprising.
Acta Obstet Gynecol Scand 79: 1037-41, 2000.
|
2000 |
|
| |
88.
Nesselhut T, Liske E:
Pharmacological measures in postmenopausal women with an isopropanolic
aqueous extract of Cimicifugae racemosae rhizoma.
Abstract No. 99.012 In: the 10th Annual Meeting of the North
American Menopause Society (NAMS),
September 23-25, 1999, New York.
|
1998 |
|
| |
89.
Nesselhut T, Schellhase C, Dietrich R, Kuhn W:
Studies on mamma carcinoma cells regarding the proliferative potential
of
herbal medications with estrogen-like effects.
Arch Gynecol
Obstet 254:817–8, 1993.
|
1993 |
|
| |
90.
Nisslein T, Freudenstein J:
Effects of Black Cohosh on urinary bone markers and femoral density
in an
OVX-rat model.
World Congress on Osteoporosis 2000, June
15 – 18, 2000, Chicago, Ill, USA.
Abstract No. 504.
|
2000 |
|
| |
91.
Nisslein T, Freudenstein J:
Effects of an isopropanolic extract of Cimicifuga racemosa on urinary
crosslinks and other parameters of bone quality in an ovariectomized
rat model of osteoporosis.
J Bone Miner Metab 21: 370-6, 2003.
|
2003 |
|
| |
92. Nisslein T, Freudenstein J:
Coadministration of the Aromatase Inhibitor Formestane and an Isopropanolic Exract of Black Cohosh in a Rat Model of Chemically Induced Mammary Carcinoma.
Planta med 2007: 73; 318-22.
|
2007
|
Hämta här
|
| |
93. Oktem M, Eroglu D, Karahan H B, Taskintuna N, Kuscu E, Zeyneloglu HB.
Black Cohosh and Fluoxetine in the Treatment of Postmenopausal Symptoms: A Prospective, Rabdomized Trial.
Advances in Therapy, 24: no.2, 2007.
|
2007
|
Hämta här |
| |
94.
Onorato J, Henion JD:
Evaluation of triterpene glycoside estrogenic activity using LC/MS and immunoaffinity extraction.
Anal Chem 73, 4704-10, 2001
|
2001
|
|
| |
95. O'Toole SA, Dunn E, Sheppard BL, Sheils O, O'Leary JJ, Wuttke W, Seidlova-Wutthe D
Oestrogen regulated gene expression in normal and malignant endometrial tissue
Maturitas 51 (2); 187-98:2005
|
2005 |
Hämta här |
| |
96.
Pethö A:
Klimakterische Beschwerden: Umstellung einer Hormonbehandlung auf
ein
pflanzliches Gynäkologikum möglich?
Ärztl Praxis
39:1551–3, 1987.
|
1987 |
|
| |
97.
Pines A:
Lessons from the Womens Health Initiative (WHI) using hormone replacement therapy with regard to heart disease — the dream that has been lost.
Harefuah 142: 163-5, 240, 2003.
|
2003 |
|
| |
98.
Popp M, Schenk R, Abel G:
Coltivation of Cimicifuga racemosa (L.) nutt. and quality of CR extract BNO 1055.
Maturitas 44, Suppl. 1, 1-7; 2003.
|
2003
|
|
| |
|
|
|
| |
Gå
till utskriftsvänlig
sida här.
|
|
|